Dermapharm Holding SE (DMP) — Strategic Asset Allocation Index
Dermapharm Holding SE (DMP) has a Strategic Asset Allocation Index of 45.4% as of December 2025. Strategic assets (PP&E of €318.54 Million plus long-term investments of €-) total €318.54 Million, measured against net assets of €701.83 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Dermapharm Holding SE balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Dermapharm Holding SE Strategic Asset Allocation Index (2014–2025)
This chart shows how Dermapharm Holding SE's Strategic Asset Allocation Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at 45.4%, representing strategic assets of €318.54 Million against net assets of €701.83 Million EUR. For live market cap and overall valuation, see DMP market cap.
Annual Strategic Asset Allocation Index for Dermapharm Holding SE (2014–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Dermapharm Holding SE from 2014 to 2025, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See DMP book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.4% | €318.54 Million | €318.54 Million | €- | €701.83 Million | ▼ -6.4 pp |
| 2024 | 51.8% | €315.03 Million | €315.03 Million | €- | €608.29 Million | ▼ -8.9 pp |
| 2023 | 60.7% | €330.77 Million | €330.77 Million | €- | €545.05 Million | ▲ +18.3 pp |
| 2022 | 42.4% | €225.67 Million | €225.67 Million | €- | €532.49 Million | ▼ -2.1 pp |
| 2021 | 44.5% | €222.29 Million | €222.29 Million | €- | €499.83 Million | ▼ -17.0 pp |
| 2020 | 61.5% | €199.62 Million | €199.62 Million | €- | €324.58 Million | ▲ +14.9 pp |
| 2019 | 46.6% | €132.59 Million | €132.59 Million | €- | €284.49 Million | ▲ +13.1 pp |
| 2018 | 33.5% | €85.73 Million | €80.87 Million | €4.85 Million | €256.08 Million | ▼ -47.7 pp |
| 2017 | 81.2% | €59.84 Million | €56.04 Million | €3.80 Million | €73.69 Million | ▼ -12.4 pp |
| 2016 | 93.6% | €56.91 Million | €53.36 Million | €3.56 Million | €60.81 Million | ▼ -63.0 pp |
| 2015 | 156.6% | €69.60 Million | €53.41 Million | €16.19 Million | €44.44 Million | ▼ -41.6 pp |
| 2014 | 198.2% | €67.42 Million | €56.55 Million | €10.87 Million | €34.01 Million | — |